| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8459440 | Radiotherapy and Oncology | 2017 | 7 Pages | 
Abstract
												Compared with standard-dose IMRT-based CCRT, high-dose IMRT-based CCRT yields more favorable survival outcomes in patients with advanced-stage TESCC.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Chia-Lun Chang, Hsieh-Chih Tsai, Wei-Cheng Lin, Jer-Hwa Chang, Han-Lin Hsu, Jyh-Ming Chow, Kevin Sheng-Po Yuan, Alexander T.H. Wu, Szu-Yuan Wu, 
											